Why buy this course?

The course you are looking at is not like any other e-Learning course you have ever taken. Watch this short video to learn why!

FDA Compliance Requirements for Opioid-Induced Oxygenation Monitors

$19.99

Stay current with the FDA’s latest classification and compliance requirements for monitors designed to detect opioid-induced impairment of oxygenation. This course delivers a precise breakdown of the new Class II classification, special controls, and actionable compliance steps for manufacturers and stakeholders. Learn about clinical and non-clinical data standards, software and hardware requirements, usability, biocompatibility, safety, labeling, and the critical 510(k) premarket notification process. Ensure your devices meet FDA requirements to support patient safety and maintain market access.

In this course you will learn the following:
* Understand the FDA’s classification process for new medical devices, specifically the De Novo pathway.
* Identify the key requirements and special controls for monitors for opioid induced impairment of oxygenation.
* Implement the necessary steps to ensure compliance with the new rule.
* Recognize the legal and regulatory consequences of failing to comply with the final order.

NOTE: Unless otherwise indicated, all course purchases are for access to the course for a period of 1-year.  At the end of the one year term, the course will be set to “inactive”. 

Why This Course is Important
Without this course, you risk missing vital updates on FDA requirements, leading to compliance gaps, potential enforcement actions, and loss of marketability for your medical devices.

Course Details
This is a self-paced eLearning course based on the Federal Register Document titled Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of Oxygenation.

Key regulatory references include:

Course SKU
FR-26-2048-1